SpaceX stock has fallen below its $135 IPO price for the first time, marking a fourth consecutive session of losses after a spectacular rally that briefly made Elon Musk a trillionaire. The decline signals a sharp reversal in investor sentiment following the company's Nasdaq-100 entry.

Early IPO buyers are now underwater on their positions, and the momentum trade that drove the stock higher has decisively broken. This matters for retail investors who chased the rally and for the broader narrative around Musk's wealth and influence tied to Tesla and SpaceX valuations.

The pullback reflects typical post-IPO volatility but also suggests caution among institutional investors about stretched valuations in the aerospace and defense sector, even for marquee names.

The United States has reinstated its blockade on Iranian ports in the Strait of Hormuz, choking off supply and sending oil prices higher. U.S. refiners are positioned to capture historic profit margins as supply disruptions widen the spread between crude and refined products.

Oil futures are ticking higher on the supply shock. U.S. refining stocks—including Valero, Phillips 66, and Marathon Petroleum—stand to see earnings surge as they process scarcer, more expensive crude into higher-margin products. Shipping costs and war risk premiums in the Strait are already climbing.

The blockade escalates geopolitical tension in the Middle East and underscores the fragility of global energy supply chains. It also benefits U.S. energy independence narratives and domestic refining capacity, a key Trump administration priority.

Morgan Stanley posted record quarterly revenue and profit, driven by a 69% surge in equities trading revenue. The beat mirrors outsized results at Goldman Sachs and JPMorgan Chase, signaling a broad resurgence in capital markets activity.

The earnings beat validates elevated trading volumes and volatility in equity markets, benefiting investment banks' trading desks. Morgan Stanley's stock should see upside, and the results suggest robust demand for capital markets services heading into year-end.

Strong equities trading across the Street reflects investor repositioning and risk appetite, likely tied to AI enthusiasm and rotation trades. It also signals healthy M&A and capital raising pipelines for the financial sector.

Eurozone industrial production fell unexpectedly in May, ending a three-month run of resilience despite elevated energy costs. The decline signals renewed weakness in manufacturing, a bellwether for the region's economic health.

The miss pressures the euro and raises questions about the ECB's rate trajectory. European cyclical stocks—industrials, autos, chemicals—may face headwinds if the slowdown persists. German manufacturing data will be critical to watch.

The stumble underscores structural challenges in European manufacturing, including energy costs and competitive pressure from China. It may force the ECB to maintain accommodative policy longer than anticipated.

Mortgage rates have risen to their highest level in nearly a year, prompting homebuyers to pause purchases. Refinancing activity saw modest gains, but purchase demand is clearly softening under the weight of higher borrowing costs.

Homebuilder stocks and mortgage lenders face headwinds as origination volumes contract. Higher rates also compress affordability, particularly for first-time buyers, pressuring residential real estate sentiment and construction starts.

Rising rates reflect sticky inflation and the Fed's commitment to restrictive policy. The housing slowdown could dampen consumer confidence and wealth effects, weighing on broader economic growth.

Johnson & Johnson posted quarterly earnings that beat Wall Street estimates, driven by strength in its medicines unit. The company also raised its full-year sales and profit forecast, signaling confidence in its pipeline and market demand.

J&J stock should see upside on the beat and raised guidance. The results validate the pharma sector's resilience and pricing power, benefiting other large-cap healthcare names like Merck and Eli Lilly.

Strong pharma earnings reflect aging demographics, innovation in specialty drugs, and pricing discipline. The sector remains a defensive play in uncertain macro conditions.

Canadian manufacturing shipments rose 1.3% to a record $55.55 billion in May, extending a four-month streak of consecutive gains. The strength suggests resilience in Canadian industrial production despite broader economic headwinds.

The data supports the Canadian dollar and may influence the Bank of Canada's rate decisions. Canadian industrial and materials stocks benefit from the manufacturing momentum, particularly exporters to the U.S.

The sustained gains reflect strong North American demand and supply chain normalization. However, the record level also suggests limited room for further expansion without demand softening.

Hedge fund liquidations reached a two-year high in the first quarter, while simultaneously a boom in new fund launches occurred. The divergence reflects a bifurcated market where winners attract capital and underperformers are shut down.

The churn creates volatility as liquidating funds unwind positions and new managers deploy capital. Hedge fund-heavy sectors and illiquid assets may see forced selling pressure, while popular strategies attract fresh inflows.

The trend underscores performance dispersion in alternative assets and the consolidation of capital toward top-tier managers. Retail and institutional investors are increasingly selective about hedge fund exposure.

UBS's theme-o-meter identifies artificial intelligence stock leadership as its top market theme, signaling that the AI bull market is returning. The call comes as earnings season unfolds and investor focus sharpens on AI-driven growth narratives.

Mega-cap AI beneficiaries—Nvidia, Microsoft, Broadcom, and others—should see renewed buying pressure. The rotation could lift the Nasdaq and tech-heavy indices while pressuring value and defensive sectors.

The resurgence of AI as a dominant theme reflects investor confidence in the secular growth narrative and willingness to pay premium valuations for exposure. It also suggests a risk-on environment and expectations for continued monetary accommodation.